// App-Quantinova.ai

S145 : FIRST RESULTS OF A HEAD-TO-HEAD TRIAL OF ACALABRUTINIB VERSUS IBRUTINIB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA

Researchers

Presenter

  • Peter Hillmen

Principal Investigators

  • Paolo Ghia

  • Arnon P Kater

  • Asher Chanan-Khan

  • Richard R Furman

  • Susan O'Brien

  • Mustafa Nuri Yenerel

  • Arpad Illes

  • Neil Kay

  • Jose A Garcia-Marco

  • Anthony Mato

  • Javier Pinilla-Ibarz

  • John F Seymour

  • Stephane Lepretre

  • Stephan Stilgenbauer

  • Tadeusz Robak

  • Priti Patel

  • Kara Higgins

  • Sophia Sohoni

  • Wojciech Jurczak

Medical Centers

  • Penn FTD Center, University of Pennsylvania Philadelphia PA United States

  • Amsterdam University Medical Center, Amsterdam, on behalf of Hovon, Amsterdam, Netherlands

  • Chao Comprehensive Cancer Center, University of California,Irvine,United States

  • The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw,Warsaw,Poland

  • University of Ulm, Ulm, Germany

  • St. James's University Hospital, Leeds, United Kingdom

  • Centre Henri Becquerel and Normandie University UNIROUEN, Rouen, France

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

  • Hospital Universitario Puerta de Hierro, Madrid, Spain

  • Medical University of Lodz, Lodz, Poland

  • Peter MacCallum Cancer Centre,...

  • AstraZeneca,South San Francisco, CA,United States

  • University of Debrecen, Debrecen, Hungary

  • Mayo Clinic, Jacksonville, Jacksonville, Florida, United States

  • Moffitt Cancer Center, Tampa, Florida, United States

  • Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, United States

  • Royal Melbourne Hospital, Victoria, Australia

  • Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

Locations

  • United States

  • Netherlands

  • Turkey

  • Poland

  • Germany

  • United Kingdom

  • France

  • Spain

  • Hungary

  • Australia

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Cardiovascular (CVS)

Disease

  • Chronic Lymphocytic Leukemia

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • ACP-196

  • Ibrutinib

Outcome

  • N/A

Study Design

  • Randomized

  • Active Comparator

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved